langerhans cell histiocytosis - Health Topics
Mixed histiocytosis (Langerhans cell histiocytosis [LCH] / Erdheim-Chester disease [ECD]) developing after treatment for initial skull LCH is not well recognized. Baylor College of Medicine: Mutated blood cells define clinical risks in Langerhans cell histiocytosis EurekAlert!: Development and successful treatment of spinal mixed histiocytosis in an elderly woman following two relapses of BRAF-mutated unifocal skull langerhans cell histiocytosis Development of mixed histiocytosis (Langerhans cell histiocytosis (LCH))/Erdheim–Chester disease (ECD)) after treatment in patients with an initial skull LCH lesion has not been well recognized. An ...
Understanding the Context
Development and successful treatment of spinal mixed histiocytosis in an elderly woman following two relapses of BRAF-mutated unifocal skull langerhans cell histiocytosis Mixed histiocytosis (Langerhans cell histiocytosis [LCH] / Erdheim-Chester disease [ECD]) developing after treatment for initial skull LCH is not well ... Concurrent enhancer of Zeste homolog 2 (EZH2) over-expression with BRAFV600E mutation predicts a poor outcome in patients with Langerhans cell histiocytosis (LCH): A pilot study. A phase 1b/2 study of ... Medical Xpress: Hemic and Lymphatic Diseases: News and Research on Histiocytosis, Langerhans-Cell A nationwide team led by researchers at Baylor College of Medicine, Texas Children’s Hospital and UPMC Children's Hospital of Pittsburgh has proposed a major revision to how Langerhans cell ...